Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests, for the first time, that Resistin, by suppressing the expression of its target gene, it may increase the expression of PDLIM5. Thereby, it may inhibit pulmonary hypertension. Together, pharmacological formulations encompassing “Resistin or its activators“ may be used to treat pulmonary arterial hypertension (PAH).
Amount: $ 300*
Undisclosed information: How Resistin increases the expression of PDLIM5
To cite: Boominathan, Molecular therapy for Pulmonary Hypertension (PAH): Resistin inhibits pulmonary hypertension via induction of PDLIM5, 8/February/2015, 14.25, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org